13G Filing: Biotechnology Value Fund LP and Capstone Therapeutics Corp (CAPS)

Page 12 of 12

Page 12 of 12 – SEC Filing

SIGNATURE

After reasonable inquiry
and to the best of his knowledge and belief, each of the undersigned certifies that the information set forth in this statement
is true, complete and correct.

Dated: July 18, 2017

BIOTECHNOLOGY VALUE FUND, L.P. BVF INC.
 
By: BVF Partners L.P., its general partner
By: BVF Inc., its general partner By: /s/ Mark N. Lampert
  Mark N. Lampert
By:

/s/ Mark N. Lampert

President
Mark N. Lampert
President
 
  /s/ Mark N. Lampert
BIOTECHNOLOGY VALUE FUND II, L.P.  MARK N. LAMPERT
 
By: BVF Partners L.P., its general partner
By: BVF Inc., its general partner
   
By:

/s/ Mark N. Lampert

Mark N. Lampert
President
 
BVF PARTNERS L.P. .
 
By: BVF Inc., its general partner
By:

/s/ Mark N. Lampert

Mark N. Lampert
President
BVF INVESTMENTS, L.L.C.
By: BVF Partners L.P., its manager
By: BVF Inc., its general partner
By:

/s/ Mark N. Lampert

Mark N. Lampert
President
12

Follow Capstone Therapeutics Corp.

Page 12 of 12